Epidemiology of interstitial lung diseases in Greece.
暂无分享,去创建一个
D. Bouros | K. Antoniou | A. Karakatsani | D. Papakosta | D. Papakosta | A. Rapti | M. Dimadi | A. Markopoulou | P. Latsi | V. Polychronopoulos | G. Birba | Labrakis Ch | V. Polychronopoulos
[1] S. Kudoh,et al. Epidemiology of sarcoidosis in Japan , 2008, European Respiratory Journal.
[2] Demosthenes Bouros,et al. Current and future therapeutic approaches in idiopathic pulmonary fibrosis , 2005, European Respiratory Journal.
[3] C. Tinelli,et al. The Italian register for diffuse infiltrative lung disorders (RIPID): a four-year report. , 2005, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[4] J. Ancochea,et al. Report on the incidence of interstitial lung diseases in Spain. , 2004, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[5] J. López-Campos,et al. Incidence of interstitial lung diseases in the south of Spain 1998–2000: The RENIA study , 2003, European Journal of Epidemiology.
[6] U. Costabel,et al. Wie werden interstitielle Lungenerkrankungen in Deutschland diagnostiziert , 2003 .
[7] N. Milman,et al. Sarcoidosis in Denmark 1980-1994. A registry-based incidence study comprising 5536 patients. , 2003, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[8] A. Nicholson,et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. , 2002, American journal of respiratory and critical care medicine.
[9] U. Costabel,et al. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias , 2002, European Respiratory Journal.
[10] T. Laitinen,et al. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland , 2002, Thorax.
[11] A. Nicholson,et al. Histopathological approach to patterns of interstitial pneumonia in patient with connective tissue disorders. , 2002, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[12] Paul J. Friedman,et al. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.
[13] R. Strawderman,et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. , 2001, American journal of respiratory and critical care medicine.
[14] J. Dalphin,et al. Hypersensitivity pneumonitis: current concepts. , 2001, The European respiratory journal. Supplement.
[15] V. Poletti,et al. Comparison of registries of interstitial lung diseases in three European countries. , 2001, The European respiratory journal. Supplement.
[16] G. Verleden,et al. Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin. , 2001, The European respiratory journal. Supplement.
[17] R. Hubbard,et al. Interstitial lung diseases: an epidemiological overview. , 2001, The European respiratory journal. Supplement.
[18] D. S. Kim. Sarcoidosis in Korea: report of the Second Nationwide Survey. , 2001, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[19] M. Demedts,et al. REGISTRATION OF INTERSTITIAL LUNG DISEASES BY 20 CENTRES OF RESPIRATORY MEDICINE IN FLANDERS , 2001, Acta clinica Belgica.
[20] A. Nicholson,et al. Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. , 2000, Radiology.
[21] D. Bouros. Current classification of idiopathic interstitial pneumonias. , 2000, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[22] A. Nicholson,et al. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. , 2000, American journal of respiratory and critical care medicine.
[23] Arnold Simanowitz,et al. international consensus statement , 2000 .
[24] W. Travis,et al. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. , 2000, The American journal of surgical pathology.
[25] David A. Lynch,et al. Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .
[26] T. Colby,et al. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. , 1998, The European respiratory journal.
[27] K P Offord,et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.
[28] H. Schweisfurth. [Report by the Scientific Working Group for Therapy of Lung Diseases: German Fibrosis Register with initial results]. , 1996, Pneumologie.
[29] J. Ruiz,et al. Epidemiology of sarcoidosis in Catalonia: 1979-1989. , 1996, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[30] M. Demedts,et al. Epidemiology of interstitial lung-disease (ild) in flanders - registration by pneumologists in 1992-1994 , 2016 .
[31] W. Black,et al. The epidemiology of interstitial lung diseases. , 1994, American journal of respiratory and critical care medicine.
[32] B. Strom,et al. Epidemiology of sarcoidosis. , 1983, Epidemiologic reviews.